Use of Ionic Liquids in the Enzymatic Synthesis of Structured Docosahexaenoic Acid Lyso-Phospholipids. [PDF]
Garcia-Quinto E+2 more
europepmc +1 more source
Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes [PDF]
Jane V. Higdon+5 more
openalex +1 more source
Abstract Essential fatty acid deficiency (EFAD) may occur in the setting of inadequate fat intake, malabsorption, malnutrition, and altered fat metabolism. Humans lack the enzymes to synthesize the essential acids linoleic acid and alpha‐linolenic acid, so they must be obtained from the diet.
Jodi Wolff+2 more
wiley +1 more source
Docosahexaenoic Acid-Infused Core-Shell Fibrous Membranes for Prevention of Epidural Adhesions. [PDF]
Liu ZH+6 more
europepmc +1 more source
Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates [PDF]
Tibor Farkas+7 more
openalex +1 more source
Thraustochytrids exhibit four distinct polyunsaturated fatty acid (PUFA) biosynthetic types: Type I (ELO/DES pathway), Type II (dual‐pathway) and Types III–IV (PUFA‐S pathway with varying gene losses). This genetic diversity in PUFA biosynthesis pathways provides new perspectives for understanding their evolutionary relationships and potential ...
Sou‐Yu Cheng+4 more
wiley +1 more source
Eicosapentaenoic Acid and Docosahexaenoic Acid as an Antimicrobial Agent in Orthopedics-An In Vitro Study About the Race for Surface. [PDF]
Spiegel C+4 more
europepmc +1 more source
Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids [PDF]
Rosemary C. Wander, Shi-Hua Du
openalex +1 more source
The Lipidomic Profile Discriminates Between MASLD and MetALD
HDL‐centric lipidomic biomarkers, particularly within large and medium HDL subfractions, distinguish metabolic dysfunction and alcohol‐related liver disease from metabolic dysfunction‐associated steatotic liver disease, suggesting potential biomarkers for clinical differentiation.
Kai Markus Schneider+15 more
wiley +1 more source